A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
Clinical trial NCT07503444 · RECRUITING
Trial details
- NCT number
- NCT07503444
- Sponsor
- UCB BIOSCIENCES, Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-14
- Primary completion
- 2029-02-06
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.